https://g.co/finance/530665:BOM
Introduction
Zenith Healthcare Limited was established in 1994. It is an Indian pharmaceutical company engaged in manufacturing pharmaceutical formulations. These include tablets, capsules, oral liquids, and injectables. The company operates across various therapeutic segments. These include antibiotics, anti-infectives, and gastrointestinal. It also includes analgesic/anti-inflammatory, cardiovascular, and respiratory. Additionally, they operate in ophthalmology, biotechnology products, oncology, and anti-retroviral. Other segments covered are the central nervous system, nutrition, genitourinary system, and dermatology.
Company Overview
Zenith Healthcare is headquartered in Changodar, Ahmedabad, Gujarat, India, and is ISO 9001:2008 and WHO-cGMP certified. The company emphasizes technological advancement, setting high benchmarks for product quality and adherence to stringent delivery schedules.
Share Price Performance
As of March 13, 2025, Zenith Healthcare’s share price is ₹4.90. Over the past six months, the share price has decreased by approximately 20.10%, and in the last year, it has decreased by 0.41%. The 52-week low for the share price was ₹4.06, and the 52-week high was ₹6.87.
Key Financial Metrics
- Market Capitalization: ₹26.4 crore
- Book Value: ₹1.41
- Return on Capital Employed (ROCE): 3.98%
- Return on Equity (ROE): 2.75%
- Face Value: ₹1.00
Recent Financial Performance
In the standalone financial results for December 2024, Zenith Healthcare reported net sales of ₹2.31 crore, marking a decrease of 40.76% year-over-year. Similarly, in September 2024, the company reported net sales of ₹3.03 crore, down from the previous year.
Investment Considerations
Investors considering Zenith Healthcare should take into account the following:
- Market Position: The company’s focus on diverse therapeutic segments positions it well within the pharmaceutical industry.
- Financial Performance: Recent declines in net sales and share price suggest potential challenges that warrant careful analysis.
- Certifications: The company’s adherence to international quality standards, such as ISO 9001:2008 and WHO-cGMP, reflects its commitment to quality.
Conclusion
Zenith Healthcare Limited is a notable entity in the Indian pharmaceutical landscape. It offers a wide range of products across various therapeutic areas. However, recent financial indicators suggest a need for cautious evaluation by investors. As with any investment, thorough research and consideration of current market conditions are essential before making investment decisions.
Sources
